The role of intravesical chemotherapy following nephroureterectomy in upper tract urothelial carcinoma: A systematic review and meta-analysis
Stefano Moretto(Humanitas University), Benjamin Pradere(Hôpital de la Croix-Rousse), Giovanni Lughezzani(Humanitas University), Andrea Gallioli(Puigvert Foundation), Nicolò Maria Buffi(Humanitas University), Morgan Rouprêt(Sorbonne Université), Michaël Baboudjian(Assistance Publique Hôpitaux de Marseille), Alessandro Uleri(Puigvert Foundation), Andrea Piccolini(Humanitas University), Alberto Breda(Universitat Autònoma de Barcelona), Bas WG van Rhijn(The Netherlands Cancer Institute), Roberto Contieri(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Urologic Oncology Seminars and Original Investigations
November 25, 2024
Cited by 8
Related Papers
Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins
|The Journal of Urology|2012|359
European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era
|European Urology|2020|313
Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old
|Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2015|227
Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro‐ureterectomy
|British Journal of Urology|2013|165